Search This Blog

Thursday, October 31, 2019

Momenta Pharmaceuticals EPS beats by $0.05, beats on revenue

Momenta Pharmaceuticals (NASDAQ:MNTA): Q3 GAAP EPS of -$0.45 beats by $0.05.
Revenue of $6.39M (-57.1% Y/Y) beats by $1.15M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)